These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 2410289
1. Reversal of deficits in axonal transport and nerve conduction velocity by treatment of streptozotocin-diabetic rats with myo-inositol. Tomlinson DR, Mayer JH. Exp Neurol; 1985 Aug; 89(2):420-7. PubMed ID: 2410289 [Abstract] [Full Text] [Related]
2. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Mayer JH, Tomlinson DR. Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336 [Abstract] [Full Text] [Related]
3. Axonal transport and nerve conduction and their relation to nerve polyol and myo-inositol levels in spontaneously diabetic BB/D rats. Mayer JH, Herberg L, Tomlinson DR. Neurochem Pathol; 1983 Nov; 2(4):285-93. PubMed ID: 6085698 [Abstract] [Full Text] [Related]
5. Essential fatty acid treatment--effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats. Tomlinson DR, Robinson JP, Compton AM, Keen P. Diabetologia; 1989 Sep; 32(9):655-9. PubMed ID: 2477293 [Abstract] [Full Text] [Related]
6. Motor nerve conduction velocity and nerve polyols in mice with short-term genetic or streptozotocin-induced diabetes. Whiteley SJ, Tomlinson DR. Exp Neurol; 1985 Aug; 89(2):314-21. PubMed ID: 3160601 [Abstract] [Full Text] [Related]
7. Methylcobalamin improves nerve conduction in streptozotocin-diabetic rats without affecting sorbitol and myo-inositol contents of sciatic nerve. Sonobe M, Yasuda H, Hatanaka I, Terada M, Yamashita M, Kikkawa R, Shigeta Y. Horm Metab Res; 1988 Nov; 20(11):717-8. PubMed ID: 3215630 [No Abstract] [Full Text] [Related]
8. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats. Mizuno K, Kato N, Matsubara A, Nakano K, Kurono M. Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819 [Abstract] [Full Text] [Related]
9. Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats. Tomlinson DR, Sidenius P, Larsen JR. Diabetes; 1986 Apr; 35(4):398-402. PubMed ID: 2420664 [Abstract] [Full Text] [Related]
13. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition. Gillon KR, Hawthorne JN, Tomlinson DR. Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913 [Abstract] [Full Text] [Related]
14. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat. Stevens MJ, Lattimer SA, Kamijo M, Van Huysen C, Sima AA, Greene DA. Diabetologia; 1993 Jul; 36(7):608-14. PubMed ID: 8359577 [Abstract] [Full Text] [Related]
15. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats. Cameron NE, Cotter MA, Robertson S. Q J Exp Physiol; 1989 Nov; 74(6):917-26. PubMed ID: 2512591 [Abstract] [Full Text] [Related]